Add 2 More Reports For 20% off

Report Overview

2024

Base Year

2018-2024

Historical Year

2025-2034

Forecast Year

Overactive Bladder Market Outlook

The overactive bladder market size is expected to grow at a CAGR of 2.52% during the forecast period of 2025-2034, driven by the rising prevalence and incidence of overactive bladder disorders and the introduction of novel treatment therapies across 8 major markets.

Overactive Bladder Market Overview

Overactive bladder (OAB) is a medical condition that causes the frequent and sudden urge to urinate. It can result in unintentional loss of urine (urgency incontinence). Overactive bladder syndrome shows a high prevalence rate of 17% in adults. In children, the incidence of overactive bladder is nearly 16.6%.  However, similar incidence rates are witnessed in men and women. The rising cases of the condition is anticipated to augment the overactive bladder market growth in the forecast period.

The surge in drugs and medical device approvals by health regulatory agencies is likely to impact the market dynamics positively. In August 2023, the United States Food and Drug Administration (FDA)  granted marketing approval to an implant called Revi System. The minimally invasive device, developed by Utah-based medical equipment supplier BlueWind Medical is aimed at treating overactive bladder. It works on neuromodulation therapy to manage symptoms of overactive bladder. The introduction of such novel treatment options in the market is likely to increase the overactive bladder market demand.

Several leading biopharmaceutical companies are actively investing in research and development activities to support the launch of potential treatment therapies for patients suffering from overactive bladder. Such strategic investments are anticipated to bolster the overactive bladder market growth. Moreover, the evolving preference for minimally invasive procedures such as neurostimulation will boost the market growth.

Overactive Bladder Market Trends

Key Trends Description
Drug and Medical Device Approvals The surge in approvals by health regulatory authorities such as FDA is expected to influence the market value significantly.
Investments in Research and Development Major biopharmaceutical companies are investing in research and development to support the launch of potential treatment therapies.
Minimally Invasive Procedures Rising preference for minimally invasive procedures such as neurostimulation is poised to boost the market growth.
Rising Prevalence The increasing prevalence of overactive bladder disorder and related conditions requiring medical intervention is driving the demand for advanced treatment options.

Overactive Bladder Market Segmentation

Market Breakup by Drug Type

  • Anti Cholinergic Drug
  • Beta 3 Adrenergic Drugs
  • Botox
  • Neurostimulation
  • Intravesical Instillation

The market segmentation by drug type includes anti-cholinergic drugs, beta-3 adrenergic drugs, botox, neurostimulation, and intravesical instillation. Catering to the diverse needs of the patients, this segmentation offers a variety of pharmacological and non-pharmacological options to treat and manage overactive bladder.

Market Breakup by Disease Type

  • Idiopathic Bladder Overactivity
  • Neurogenic Bladder Overactivity

The overactive bladder market share is segmented by disease type into idiopathic bladder overactivity and neurogenic bladder overactivity. Idiopathic bladder overactivity is characterized by overactive bladder symptoms without a known underlying cause whereas neurogenic bladder overactivity occurs as a result of underlying neurological conditions.

Market Breakup by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

The distribution channels in the market include hospital pharmacies, retail pharmacies, online pharmacies, and others. To ensure accessibility and availability of overactive bladder treatments, this segment offers various channels to cater to the growing patient base.

Market Breakup by Region

  • United States
  • EU-4 and the United Kingdom
    • Germany
    • France
    • o    Italy
    • o    Spain
    • o    United Kingdom
  • Japan
  • India

Based on the region, the market includes the United States, EU-4 (Germany, France, Italy, Spain), the United Kingdom, Japan, and India. North America dominates the regional market, with factors such as the presence of key market players along with a robust healthcare system. The rise in the launch of novel therapies in the region further bolsters the market growth.

Overactive Bladder Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Pfizer Inc.
  • Sumitomo Pharma Co., Ltd
  • Laborie
  • Endo International PLC
  • Hisamitsu Pharmaceutical Co., Inc.
  • Medtronic
  • Urovant Sciences

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2018-2024
Forecast Period 2025-2034
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Drug Type
  • Disease Type
  • Distribution Channel
  • Region
Breakup by Drug Type
  • Anti Cholinergic Drug
  • Beta 3 Adrenergic Drugs
  • Botox
  • Neurostimulation
  • Intravesical Instillation  
Breakup by Disease Type
  • Idiopathic Bladder Overactivity
  • Neurogenic Bladder Overactivity 
Breakup by Distribution Channel
  • Hospital Pharmacy 
  • Retail Pharmacy 
  • Online Pharmacy 
  • Others
Breakup by Region
  • United States
  • EU-4 and the United Kingdom
  • Japan
  • India 
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • AbbVie Inc.
  • Astellas Pharma Inc.  
  • Pfizer Inc.
  • Sumitomo Pharma Co., Ltd
  • Laborie 
  • Endo International PLC
  • Hisamitsu Pharmaceutical Co., Inc.
  • Medtronic 
  • Urovant Sciences

Key Queries Solved in the Overactive Bladder Market Report

  • How will the market landscape evolve in the forecast period? 
  • What are the leading factors driving the growth of the market?
  • What are the strategic investments being made by biopharmaceutical companies to develop novel drugs for overactive bladder treatment?
  • Which diseases and conditions majorly contribute to the prevalence of the overactive bladder?
  • What is the current incidence of overactive bladder, and how is it expected to impact the overactive bladder market size?
  • Which drug type is predicted to dominate the overactive bladder market?
  • What are the emerging trends in minimally invasive procedures for overactive bladder management, and how do they influence market dynamics?
  • What are the challenges and constraints in the market?
  • How do regulatory frameworks and reimbursement policies impact the market landscape?
  • What are the key market segments and their respective growth trajectories?
  • What are the competitive dynamics among key players in the market?
  • What are the opportunities for growth and innovation in the overactive bladder market in the coming years?

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market is anticipated to grow at a CAGR of 2.52% during the forecast period of 2025-2034, driven by the rising incidence of overactive bladder disorders and the introduction of novel treatment therapies in the market.

 The rise in novel product launches to treat overactive bladder syndrome is fuelling the demand for the market.

One of the significant trends in the market is the surge in drug and medical device approvals from health regulatory agencies such as the FDA. In August 2023, the United States Food and Drug Administration (FDA) offered marketing approval to BlueWind Medical's Revi System, an implant aimed to treat overactive bladder.

Based on the disease type, the market is segmented into idiopathic bladder overactivity and neurogenic bladder overactivity.

Based on the drug type, the market is segmented into anti-cholinergic drugs, beta-3 adrenergic drugs, Botox, neurostimulation, and intravesical instillation.

The distribution channels in the market include hospital pharmacies, retail pharmacies, online pharmacies, and others.

The major regions of the market include the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. 

Key players involved in the market are AbbVie Inc., Astellas Pharma Inc., Pfizer Inc., Sumitomo Pharma Co., Ltd, Laborie, Endo International PLC, Hisamitsu Pharmaceutical Co., Inc., Medtronic, and Urovant Sciences.

Datasheet

10 % Off

USD

3,299

2,969

Single User License

10 % Off

USD

5,499

4,969

Five User License

15 % Off

USD

6,999

5,949

Corporate License

15 % Off

USD

8,199

6,969

Datasheet

One User

USD 3,299

USD 2,969

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 5,499

USD 4,969

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 6,999

USD 5,949

tax inclusive*

  • All Selected Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 8,199

USD 6,969

tax inclusive*

  • All Selected Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complementary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124